🎁 Black Friday: up to 50% off of annual plans
Bio-Gate AG (FRA:BIG)
Germany flag Germany · Delayed Price · Currency is EUR
1.940
0.00 (0.00%)
At close: Nov 20, 2026

Bio-Gate AG Statistics

Total Valuation

Bio-Gate AG has a market cap or net worth of EUR 3.96 million. The enterprise value is 6.48 million.

Market Cap3.96M
Enterprise Value 6.48M

Important Dates

The next estimated earnings date is Thursday, December 10, 2026.

Earnings Date Dec 10, 2026
Ex-Dividend Date n/a

Share Statistics

Bio-Gate AG has 2.04 million shares outstanding. The number of shares has increased by 10.28% in one year.

Current Share Class 2.04M
Shares Outstanding 2.04M
Shares Change (YoY) +10.28%
Shares Change (QoQ) -8.53%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.58
PB Ratio 7.25
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.95
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.16, with a Debt / Equity ratio of 4.15.

Current Ratio 2.16
Quick Ratio 0.46
Debt / Equity 4.15
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10.45

Financial Efficiency

Return on equity (ROE) is -174.61% and return on invested capital (ROIC) is -33.73%.

Return on Equity (ROE) -174.61%
Return on Assets (ROA) -18.67%
Return on Invested Capital (ROIC) -33.73%
Return on Capital Employed (ROCE) -40.26%
Weighted Average Cost of Capital (WACC) 4.41%
Revenue Per Employee 141,508
Profits Per Employee -27,437
Employee Count48
Asset Turnover 1.67
Inventory Turnover 1.99

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -51.80% in the last 52 weeks. The beta is 0.12, so Bio-Gate AG's price volatility has been lower than the market average.

Beta (5Y) 0.12
52-Week Price Change -51.80%
50-Day Moving Average 2.38
200-Day Moving Average 2.83
Relative Strength Index (RSI) 20.16
Average Volume (20 Days) 54

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Bio-Gate AG had revenue of EUR 6.79 million and -1.32 million in losses. Loss per share was -0.65.

Revenue6.79M
Gross Profit 3.77M
Operating Income -1.21M
Pretax Income -1.33M
Net Income -1.32M
EBITDA -982,791
EBIT -1.21M
Loss Per Share -0.65
Full Income Statement

Balance Sheet

The company has 78,418 in cash and 2.54 million in debt, with a net cash position of -2.46 million or -1.21 per share.

Cash & Cash Equivalents 78,418
Total Debt 2.54M
Net Cash -2.46M
Net Cash Per Share -1.21
Equity (Book Value) 612,014
Book Value Per Share 0.27
Working Capital 1.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.06 million and capital expenditures -3,000, giving a free cash flow of -1.06 million.

Operating Cash Flow -1.06M
Capital Expenditures -3,000
Depreciation & Amortization 232,000
Net Borrowing 410,000
Free Cash Flow -1.06M
FCF Per Share -0.52
Full Cash Flow Statement

Margins

Gross margin is 55.43%, with operating and profit margins of -17.88% and -19.39%.

Gross Margin 55.43%
Operating Margin -17.88%
Pretax Margin -19.65%
Profit Margin -19.39%
EBITDA Margin -14.47%
EBIT Margin -17.88%
FCF Margin n/a

Dividends & Yields

Bio-Gate AG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -10.28%
Shareholder Yield -10.28%
Earnings Yield -33.30%
FCF Yield -26.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Analyst Forecast

The average price target for Bio-Gate AG is 8.76, which is 351.44% higher than the current price. The consensus rating is "Buy".

Price Target 8.76
Price Target Difference 351.44%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (3Y) 2.98%
EPS Growth Forecast (3Y) n/a

Stock Splits

The last stock split was on July 28, 2026. It was a reverse split with a ratio of 0.2.

Last Split Date Jul 28, 2026
Split Type Reverse
Split Ratio 0.2

Scores

Bio-Gate AG has an Altman Z-Score of -3.18 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.18
Piotroski F-Score 3